Related Experiment Videos

Immunomodulatory therapy of human type 1 diabetes: lessons from the mouse

¹Department of Medicine, University of Washington, Seattle, USA. jpp@u.washington.edu

The Journal of Clinical Investigation

|July 4, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Genes and immunity·2015

Islet autoimmunity in phenotypic type 2 diabetes patients.

Diabetes, obesity & metabolism·2013

Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.

Clinical and experimental immunology·2013

Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.

Clinical and experimental immunology·2011

Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

The Journal of clinical endocrinology and metabolism·2010

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Genes and immunity·2010

See all related articles